In Vivo cimetidine inhibits hepatic CYP2C6 and CYP2C11 but not CYP1A1 in adult male rats

Journal of Pharmacology and Experimental Therapeutics

Volumn 284, Issue 2, 1998, Pages 493-499

  Levine, Marc ^a   Law, Eva Y W ^a   Bandiera, Stelvio M ^a   Chang, Thomas K H ^a   Bellward, Gail D ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BETA NAPHTHOFLAVONE; CIMETIDINE; CYTOCHROME; ETHOXYRESORUFIN DEETHYLASE; IMMUNOGLOBULIN G ANTIBODY; MONOCLONAL ANTIBODY; OXYGENASE; PHENOBARBITAL; POLYCLONAL ANTIBODY; STEROID 21 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUOROMETRY; IMMUNOBLOTTING; INTRAPERITONEAL DRUG ADMINISTRATION; LIVER MICROSOME; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0031885475     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Adedoyin A, Aarons L and Houston JB (1987) Plasma concentration-response relationship for cimetidine inhibition of drug metabolism in the rat. Drug Metab Dispos. 15:127-132.
2. Bourrie M, Meunier V, Berger Y and Fabre G (1996) Cytochrome P450 isoform inhibitors as a tool for the investigation of metabolic reactions catalyzed by human liver microsomes. J Pharmacol Exp Ther 277:321-332.
3. Burke MD and Mayer RT (1974) Ethoxyresorufin: Direct fluorimetric assay of a microsomal O-dealkylation which is preferentially inducible by 3-methylcholanthrene. Drug Metab Dispos 2:583-588.
4. Burke MD, Thompson S, Elcombe CR, Halpert J, Haaparanta T and Mayer RT (1985) Ethoxy-, pentoxy- and benzyloxyphenoxazones and homologues: A series of substrates to distinguish between different induced cytochromes P-450. Biochem Pharmacol 34:3337-3345.
5. Burke MD, Thompson S, Weaver RJ, Wolf RC and Mayer RT (1994) Cytochrome P450 specificities of alkoxyresorufin O-dealkylation in human and rat liver. Biochem Pharmacol 48:923-936.
6. Chang T, Levine M, Bandiera SM and Bellward GD (1992a) Selective inhibition of fat hepatic microsomal Cytochrome P-450. I. Effect of the in vivo administration of cimetidine. J Pharmacol Exp Ther 260:1441-1449.
7. Chang T, Levine M and Bellward GD (1992b) Selective inhibition of rat hepatic microsomal Cytochrome P-450. II. Effect of the in vitro administration of cimetidine. J Pharmacol Exp Ther 260:1450-1455.
8. Chang TKH, Teixeira J, Gil G and Waxman DJ (1993) The lithocholic acid 6β-hydroxylase Cytochrome P-450, CYP3A10, is an active catalyst of steroid hormone 6β-hydroxylation. Biochem J 291:429-434.
9. Clarke SE, Ayrton AD and Chenery RJ (1994) Characterization of the inhibition of P450 1A2 by furafylline. Xenobiotica 24:517-526.
10. Drew R, Rowell J and Grygiel JJ (1981) Cimetidine: A specific inhibitor of hepatic aryl hydrocarbon hydroxylase (AHH) in the rat. Res Commun Chem Pathol Pharmacol 33:81-93.
11. Galbraith RA and Jellinck PH (1989) Decreased estrogen hydroxylation in male rat liver following cimetidine treatment. Biochem Pharmacol 38:313-319.
12. Guengerich FP, Dannan GA, Wright ST, Martin MV and Kaminsky LS (1982) Purification and characterization of liver microsomal Cytochrome P450: Electrophoretic, spectral, catalytic, and immunochemical properties and inducibility of eight isozymes isolated from rats treated with phenobarbital or β-naphthoflavone. Biochemistry 21:6019-6030.
13. Hietanen E, Ahotupa M, Beriziat JC, Park SS, Gelboin HV and Bartsch H (1987) Monoclonal antibody characterization of hepatic and extrahepatic Cytochrome P-450 activity in rats treated with 3-methylcholanthrene or phenobarbital and fed various cholesterol diets. Biochem Pharmacol 36:3973-3980.
14. Hoensch HP, Hutzel H, Kirch W and Ohnhaus EE (1985) Isolation of human hepatic microsomes and their inhibition by cimetidine and ranitidine. Eur J Clin Pharmacol 29:199-206.
15. Jensen JC and Gugler R (1985) Cimetidine interaction with liver microsomes in vitro and in vivo: Involvement of an activated complex with Cytochrome P450. Biochem Pharmacol 34:2141-2146.
16. Kao LR and Wilkinson CF (1987) Inhibition of cytochrome P-450c-mediated benzo-[a]pyrene hydroxylase and ethoxyresorufin O-deethylase by dihydrosafrole. Xenobiotica 17:793-805.
17. Kelley M, Hantelle P, Safe S, Levin W and Thomas PE (1987) Co-induction of Cytochrome P-450 isozymes in rat liver by 2,4,5,2′,4′,5′-hexachlorobiphenyl or 3-methoxy-4-aminoazobenzene. Mol Pharmacol 32:206-211.
18. Knodell RG, Browne DG, Gwozdz GP, Brian WR and Guengerich FP (1991) Differential inhibition of individual human liver cytochromes P-450 by cimetidine. Gastroenterology 101:1680-1691.
19. 2-receptor antagonists. Gastroenterology 82:84-88.
20. Leclercq V, Desager JP, Horsmans Y, Van Nieuwenhuyze Y, and Harvengt C (1989) Influence of rifampicin, phenobarbital and cimetidine on mixed function monooxygenase in extensive metabolizers of debrisoquine. Int J Clin Pharmacol Ther Toxcicol 27:593-598.
21. Levine M and Bellward GD (1995) Effect of cimetidine on hepatic cytochrome P450: Evidence for formation of a metabolite-intermediate complex. Drug Metab Dispos 23:1407-1411.
22. LuAYH and Levin W (1972) Partial purification of cytochrome P-450 and P-448 from rat liver microsomes. Biochem Biophys Res Commun 46:1334-1339.
23. Nakajima T, Elovaara E, Park SS, Gelboin HV, Hietanen E and Vainio H (1990) Monoclonal antibody-directed characterization of benzene, ethoxyresorufin and pentoxyresorufin metabolism in rat liver microsomes. Biochem Pharmacol 40: 1225-1261.
24. Nerurkar PV, Park SS, Thomas PE, Nims RW and Lubet RA (1993) Methoxyresorufin and benzyloxyresorufin: Substrates preferentially metabolized by cytochromes P4501A2 and 2B, respectively, in the rat and mouse. Biochem Pharmacol 46:933-943.
25. Newton DJ, Wang RW and Lu AYH (1995) Cytochrome P450 inhibitors: Evaluation of specificities in the in vitro metabolism of therapeutic agents by human liver microsomes. Drug Metab Dispos 23:154-158.
26. Omura T and Sato R (1964) The carbon monoxide binding pigment of liver microsomes. II. Solubilization, purification and properties. J Biol Chem 239:2379-2385.
27. Park SS, Fujino T, West D, Guengerich FP and Gelboin HV (1982) Monoclonal antibodies that inhibit enzyme activity of 3-methylcholanthrene-induced cytochrome P-450. Cancer Res 42:1798-1808.
28. Pelkonen O and Puurunen J (1980) The effect of cimetidine on in vitro and in vivo microsomal drug metabolism in the rat. Biochem Pharmacol 29:3075-3080.
29. Phillipson CE, Ioannides C, Barrett DCA and Parke DV (1985) The homogeneity of rat liver microsomal cytochrome P-448 activity and its role in the activation of benzo[a]pyrene to mutagens. Int J Biochem 17:37-42.
30. 2-receptor antagonists. Xenobiotica 18:381-387.
31. Rendic S, Sunjic V, Toso R and Kajfez F (1979) Interaction of cimetidine with liver microsomes. Xenobiotica 9:555-564.
32. Roos PH and Mahnke A (1996) Metabolite complex formation of orphenadrine with cytochrome P450: Involvement of CYP2C11 and CYP3A isozymes. Biochem Pharmacol 52:73-84.
33. Ryan DE, Iida S, Wood A, Thomas PE, Lieber CS and Levin W (1984) Characterization of three highly purified rat hepatic cytochromes P-450 from hepatic microsomes of adult male rats. J Biol Chem 259:1239-1250.
34. Ryan DE, Thomas PE, Reik M and Levin W (1982) Purification and characterization of five rat hepatic microsomal cytochrome P-450 isozymes. Xenobiotica 12:727-744.
35. Sesardic D, Boobis AR, Murray BP, Murray S, Segura J, de la Torre R and Davies DS (1990) Furafylline is a potent and selective inhibitor of cytochrome P450IA2 in man. Br J Clin Pharmacol 29:651-663.
36. Somogyi A and Gugler R (1982) Drug interactions with cimetidine. Clin Pharmacokinet 7:23-41.
37. Somogyi A and Muirhead M (1987) Pharmacokinetic interactions of cimetidine: 1987. Clin Pharmacokinet 12:321-366.
38. 2-receptor antagonists studied in vivo and in vitro in rodents. Gastroenterology 82:89-96.
39. Swinney DC, Ryan DE, Thomas PE and Levin W (1987) Regioselective progesterone hydroxylation catalyzed by eleven rat hepatic cytochrome P-450 isozymes. Biochemistry 26:7073-7083.
40. Thomas PE, Reik LM, Ryan DE and Levin W (1983) Induction of two immunochemically related rat liver cytochrome P-450 isozymes, cytochromes P-450c and P-450d, by structurally diverse xenobiotics. J Biol Chem 258:4590-4598.
41. Thomas PE, Reik LM, Ryan DE and Levin W (1984) Characterization of nine monoclonal antibodies against rat hepatic cytochrome P-450c: Delineation of at least five spatially distinct isotopes. J Biol Chem 259:3890-3899.
42. Vage C and Svensson CK (1994) Evidence that the biotransformation of dapsone and monoacetyldapsone to their respective hydroxylamine metabolites in rat liver microsomes is mediated by cytochrome P450 2C6/2C11 and 3A1. Drug Metab Dispos 22:572-577.
43. Waxman DJ (1984) Rat hepatic cytochrome P-450 isoenzyme 2C: Identification as a male-specific developmentally induced steroid 16α-hydroxylase and comparison to a female-specific cytochrome P-450 isoenzyme. J Biol Chem 259:15481-15490.
44. Waxman DJ (1991) P-450 catalyzed steroid hydroxylation: Assay and product identification by thin-layer chromatography. Methods Enzymol 206:462-476.
45. 4-5α-reductase. Drug Metab Dispos 23:383-392.
46. Winzor DJ, Ioannoni B and Reilly PEB (1986) The nature of microsomal monooxygenase inhibition by cimetidine. Biochem Pharmacol 35:2157-2161.
47. 19 steroids by five highly purified and reconstituted rat hepatic cytochrome P-450 isozymes. J Biol Chem 258:8839-8847.